Op deze pagina vind je onze gerelateerde gepubliceerde artikels. 

  • Tempelman HA, van der Meer JTM, Gardeniers AC. Ndlovu Autonomous Treatment Center: een model voor geïntegreerde zorg op het platteland van Zuid-Afrika. Tijdschrift voor Infectieziekten 2008;3(5s):33-6
  • A Schoffelen ; A Wensing ; H Tempelman ; S Geelen ; A Hoepelman ; R Barth Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa Journal of the International AIDS Society, 01 November 2012, Vol.15(6(Suppl 4)), pp.1-1
  • Barth, Re ; Aitken, SC ; Tempelman, H ; Geelen, Sp ; van Bussel, Em ; Hoepelman, AIM ; Schuurman, R ; Wensing, Amj. Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients. Antiviral Therapy, 2012, Vol.17(2), pp.377-386
  • Schoffelen, Annelot F ; De Groot, Eric ; Tempelman, Hugo A ; Visseren, Frank L. J ; Hoepelman, Andy I. M ; Barth, Roos E. Carotid Intima Media Thickness in Mainly Female HIV-Infected Subjects in Rural South Africa: Association With Cardiovascular but Not HIV-Related Factors. Clinical Infectious Diseases, 2015, Vol. 61(10), pp.1606-1614

  • Barth, R. ; Meer, J. ; Hoepelman, A. ; Schrooders, P. ; Vijver, D. ; Geelen, S. ; Tempelman, H. Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. European Journal of Clinical Microbiology & Infectious Diseases, 2008, Vol.27(10), pp.977-984

  • Schoffelen, Annelot F. ; Hoepelman, Andy I. M. ; Barth, Roos E. ; Wensing, Annemarie M. J. ; Tempelman, Hugo A. ; Geelen, Sibyl P. M. Sustained Virological Response on Second-Line Antiretroviral Therapy following Virological Failure in HIV-Infected Patients in Rural South Africa. PLoS ONE, 11 March 2013, Vol.8(3)

  • Barth, Roos E. ; Mudrikova, Tania ; Hoepelman, Andy I.M. ; Huijgen, Quirine ; Tempelman, Hugo A. ; Wensing, Annemarie M.J. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa. Journal of Medical Virology, June 2011, Vol.83(6), pp.929-934

  • Barth, Roos E ; Tempelman, Hugo A ; Moraba, Robert ; Hoepelman, Andy I. M Kallas, Esper. Long- Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early Mortality. AIDS Research and Treatment, 2011, Vol.2011, 5 pages

  • Barth, Roos E. MD, PhD*; Tempelman, Hugo A. MD†; Smelt, Elbert MD*; Wensing, Annemarie M. J. MD, PhD‡; Hoepelman, Andy I. MD, PhD*; Geelen, Sibyl P. MD, PhD§ Long-term Outcome of Children Receiving Antiretroviral Treatment in Rural South Africa: Substantial Virologic Failure on
    First-line Treatment. Pediatric Infectious Disease Journal:January 2011 – Volume 30 – Issue 1 – pp 52- 56

  • Barth, Roos E; Wensing, Annemarie M; Tempelman, Hugo A; Moraba, Robert; Schuurman, Rob; Hoepelman, Andy I. Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa. AIDS:18 October 2008 – Volume 22 – Issue 16 – p 2210–2212

  • Hilde Diteweg, Adinda van Oostwaard, Hugo Tempelman, Adri Vermeer, Melanie Appels, Marieke F. van der Schaaf, David J.F. Maree., AIDS awareness and VCT behaviour: An application of the integrated model of behaviour prediction. Health SA Gesondheid 18(1), Art. #530, 10 pages.

  • Lucas E Hermans, Michelle Moorhouse, Sergio Carmona, Diederick E Grobbee, L Marije Hofstra, Douglas D Richman, Hugo A Tempelman, Willem D F Venter, Annemarie M J Wensing Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. Lancet Infectious Diseases November 2017

  • Hermans LE, Moorhouse M, Carmona S, Grobbee DE, Hofstra LM, Richman DD, Tempelman HA, Venter WDF, Wensing AMJ. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. Lancet Infect Dis. 2018 Feb;18(2):188-197.